Gene · 26047
Papers3,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and molecular mechanisms of the FOXP2-CNTNAP2 pathway in Autism spectrum disorders and speech disorders. | J Neural Transm (Vienna) | 2026 | 42455320 | PubTator, text mining | PubMed |
| Clinical characteristics and prognosis of antibody-mediated autoimmune encephalitis: A single-center cohort study in Liuzhou, China. | Medicine (Baltimore) | 2026 | 42432914 | PubTator, text mining | PubMed |
| [Autoimmune limbic encephalitis with concurrent positivity for Caspr2 and GFAPα antibodies]. | Rinsho Shinkeigaku | 2026 | 42419931 | PubTator, text mining | PubMed |
| "Un chapeau" can fit many different heads - A clinical vignette for CASPR2 autoimmune encephalitis. | Epileptic Disord | 2026 | 42417544 | PubTator, text mining | PubMed |
| A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE. | Ann Neurol | 2026 | 42410660 | PubTator, text mining | PubMed |
| [Utility of acute-phase cerebral blood flow single photon emission computed tomography (SPECT) for evaluating the pathophysiology of Bickerstaff brainstem encephalitis with decorticate posturing]. | Rinsho Shinkeigaku | 2026 | 42402382 | PubTator, text mining | PubMed |
| Oxygen-ozone action on Isaac's syndrome: a case report. | Eur Rev Med Pharmacol Sci | 2026 | 42396931 | PubTator, text mining | PubMed |
| Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort. | Hum Mutat | 2026 | 42388363 | PubTator, text mining | PubMed |
| Semaglutide treatment in MOSH is associated with altered DNA methylation patterns of genes related to glycolipid metabolism. | Sci Rep | 2026 | 42336886 | PubTator, text mining | PubMed |
| Screening 1021 Swedish memory clinic visitors for autoantibody-mediated encephalitis. | J Neurol | 2026 | 42322434 | PubTator, text mining | PubMed |
| High-Affinity Human Germline and Mutated Autoantibodies Commonly Cross-React to Self-Antigens in 5 Subgroups of Autoimmune Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42308457 | PubTator, text mining | PubMed |
| The Tumor-suppressive role of CNTNAP2 in glioma: Dual regulation of the NDN-ERK axis and M2 macrophage polarization. | Cancer Gene Ther | 2026 | 42271032 | PubTator, text mining | PubMed |
| CASPR2 antibody-positive glioblastoma-associated pseudoparaneoplastic syndrome: a case report. | Front Immunol | 2026 | 42220491 | PubTator, text mining | PubMed |
| Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42214057 | PubTator, text mining | PubMed |
| Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women. | BMC Cancer | 2026 | 42174462 | PubTator, text mining | PubMed |
| CNTNAP2: isoform- and context-specific functions in neurological disorders and cancer. | Front Cell Neurosci | 2026 | 42110583 | PubTator, text mining | PubMed |
| Proteomic identification and validation of novel neuronal EV-based markers for Alzheimer's disease biomarker discovery. | bioRxiv | 2026 | 42094463 | PubTator, text mining | PubMed |
| The cascade to pathogenicity in autoantibody-mediated CNS diseases. | Brain | 2026 | 42081370 | PubTator, text mining | PubMed |
| [Rapidly progressive cognitive impairment as a single clinical manifestation of anti-NMDA receptor encephalitis]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2026 | 42054334 | PubTator, text mining | PubMed |
| Screening for serum antineuronal antibodies in pediatric epilepsy. | Brain Dev | 2026 | 42025277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26047/papers?page=2